As reviewed in recent posts, bipolar I and bipolar II disorders are associated with substantial functional impairments and increased mortality. Depressive episodes associated with bipolar disorder do ...

Bipolar disorder doesn't just affect mood—it actively reshapes the brain. A new two-year study found that a patient's gray matter volume fluctuates dramatically depending on whether they are ...

A new study led by University of Chicago researchers suggests a significant link between exposure to environmental pollution and an increase in the prevalence of neuropsychiatric disorders. Based on ...

A study, published this month in the journal JAMA Psychiatry, sought to determine whether “a single psychedelic dose of psilocybin with psychotherapy demonstrate[s] evidence for efficacy and/or safety ...

October 9, 2012 (Montreal, Canada) — The first 6 months postpartum carry a significantly higher risk for women with major depressive disorder (MDD) to convert to bipolar disorder (BD) compared with ...

Baylor College of Medicine received nearly $10 million in funding from the NIH BRAIN Initiative to study effective treatments for the depressive phase of bipolar disorder. In the span of five years, ...

A study led by a UCLA Neuropsychiatric Institute researcher challenges standard treatment guidelines for bipolar depression that recommend discontinuing antidepressants within the first six months ...

Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be used ...

Diagnosing bipolar disorder can be difficult. While it is not hard to distinguish between its two characteristic phases—the high spirits of mania and the low spirits of depression—it is challenging to ...

Rula reports five common triggers of bipolar disorder: stress, sleep issues, seasonal changes, substance use, and hormonal ...